Help us fight
Coronavirus
You can support our groundbreaking COVID-19
research by making a contribution today.
ISB Co-founder, Chief Strategy Officer and Professor Dr. Lee Hood is credited with coining the term “systems biology,” and has been a longtime advocate of P4 medicine (predictive, preventive, personalized and participatory).
Now, Hood has been selected by the Los Angeles Times to share his insights in a new weekly op-ed column, called Second Opinion.
The column “aims to engage cutting-edge debates about the unprecedented global challenges that our society faces” and “will feature contributions from thought leaders, scientists, diplomats, humanitarians, artists, economists, and other experts who will offer their insights into these challenges, in an effort to identify solutions and actions to solve them,” said Dr. Patrick Soon-Shiong, executive chairman of the L.A. Times, in an article announcing the weekly column.
Hood has penned two columns, and more are in the works. The Second Opinion columns are published in print in Sunday Los Angeles Times newspapers and appear on latimes.com. They are also syndicated by Yahoo News and many other outlets. Prior to the launch of Second Opinion, Hood and author Matthew LaPlante wrote an op-ed for the Los Angeles Times.
Image Courtesy Claire Reid / Los Angeles Times; Getty Images, Unsplash
Op-Ed: The key to treating Alzheimer’s disease may not be a drug
June 30, 2021
Image courtesy Los Angeles Times / Nicole Vas
Second Opinion: How long haul COVID could offer clues for treating other puzzling illnesses
April 18, 2021
Category: Dr. Lee Hood
Tags:columnist, COVID, Dr. Lee Hood, Dr. Leroy Hood, LA Times, Lee Hood, Los Angeles Times, Op-Ed, P4 medicine, Second Opinion, STEM education
A just-published study provides new information about which hospitalized COVID-19 patients are most likely to need mechanical ventilation or to die. The ISB-led work shows that vital signs and lab results at the time of hospital admission are the most accurate predictors of disease severity, more so than comorbidities and demographics.
Researchers have identified several factors that can be measured at the initial point of COVID-19 diagnosis that anticipate if a patient is likely to develop long COVID. They also found that mild cases of COVID-19, not just severe cases, are associated with long COVID. Their findings were published by the journal Cell.
An ISB-led study examined the electronic health records of more than 18,000 people with SARS-CoV-2 tests during pregnancy, and found that those who contracted COVID-19 while pregnant were more likely to have poor birth outcomes including preterm birth, small for gestational age, low birth weight, and stillbirth.
You can support our groundbreaking COVID-19
research by making a contribution today.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.